StoneCrest Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
584
-6,569
-92% -$1.74M 0.09% 68
2026
Q1
$784K Sell
7,153
-447
-6% -$63.7K 0.33% 49
2025
Q4
$1.26M Buy
7,600
+189
+3% +$31.6K 0.51% 44
2025
Q3
$1.45M Buy
7,411
+431
+6% +$70.9K 0.64% 39
2025
Q2
$631K Buy
6,980
+1,632
+31% +$129K 0.3% 52
2025
Q1
$319K Buy
+5,348
New +$495K 0.2% 61

Other funds holding ALAB

StoneCrest Wealth Management's ALAB Position: Q2 2026 in Review

StoneCrest Wealth Management reduced its Astera Labs (ALAB) stake by 92% in Q2 2026, selling an estimated $1.74M and leaving 584 shares worth $282K. The position accounts for 0.09% of the portfolio, ranked #68.

StoneCrest Wealth Management first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.45M in Q3 2025. 107 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • StoneCrest Wealth Management held 584 shares of Astera Labs worth $282K as of Q2 2026.
  • StoneCrest Wealth Management sold 6,569 Astera Labs shares in Q2 2026, an estimated $1.74M.
  • Astera Labs made up 0.09% of StoneCrest Wealth Management's portfolio in Q2 2026, its #68 holding.
  • StoneCrest Wealth Management first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • StoneCrest Wealth Management's Astera Labs position peaked at $1.45M in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on StoneCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.